MedDataX Logo

Effectiveness of Neuromuscular Kinesiology Taping in Plantar Fasciitis

NCT ID: NCT05328700

Last Updated: 2023-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-15

Study Completion Date

2022-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

One of the pathologies most studied and treated with kinesiotape (KT) is plantar fasciitis (PF). In most of the studies reviewed, it is concluded that there is an improvement in the symptoms of PF when treated with KT: either combined with other therapies or as a single treatment compared to placebo. However, most current studies have limitations because the sample is small, the effect size is small, and the evidence is insufficient or of low quality.

In the present work, the aim is to study the effectiveness of KT in PF, and to compare the results with those obtained in a placebo group, which is treated with tape. The researchers will assess the decrease in symptoms prior to performing other definitive treatments. In addition, the variability of the painful symptoms and the durability of the bandage will be studied, in order to determine whether it can be used in the short or long period of time, being able to take it into account and supposing a supplement to the pharmacological treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fasciitis, Plantar

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

kinesiotaping

Group Type EXPERIMENTAL

Kinesiotaping

Intervention Type OTHER

Perform a neuromuscular bandage with kinesiotape in patients with plantar fasciitis

Tape

Group Type PLACEBO_COMPARATOR

Tape

Intervention Type OTHER

Perform a neuromuscular bandage with tape (Hipofix(R)) in patients with plantar fasciitis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesiotaping

Perform a neuromuscular bandage with kinesiotape in patients with plantar fasciitis

Intervention Type OTHER

Tape

Perform a neuromuscular bandage with tape (Hipofix(R)) in patients with plantar fasciitis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People with acute plantar fasciitis with less than 3 months of evolution
* Who present pain in the fascia both during ambulation and on palpation
* Ecographic image compatible with plantar fasciitis (\> 4 mm)
* The condition has not be previously treated with other treatment

Exclusion Criteria

* Condition with no sintomatology
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Valencia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

CARMEN GARCÍA GOMARIZ

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitat de València

Valencia, Valencia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VNM_CC

Identifier Type: -

Identifier Source: org_study_id